Reidel’s thyroiditis and Tolosa-Hunt syndrome, a rare association

Khan, Madiha; Hashmi, Syed Maroof; Prinsley, Peter; Premachandra, D. J.

doi:10.1258/002221504772784676

Cited by 8 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The bibliographical search revealed 536 articles, 48 of which met the criteria to be included (8–11, 13–56). Overall we included 62 subjects extracted from 48 reports: 38 in the THS group (three of which showed a normal MRI and three were not treated), 16 in the THS plus group and eight in the OM group.…”

Section: Resultsmentioning

confidence: 99%

ICHD-II Diagnostic Criteria for Tolosa—Hunt Syndrome in Idiopathic Inflammatory Syndromes of the Orbit and/or the Cavernous Sinus

et al. 2008

View full text Add to dashboard Cite

A bibliographical search was conducted for papers published between 1999 and 2007 to verify the validity of International Classification of Headache Disorders (ICHD)-II criteria for the Tolosa-Hunt syndrome (THS) in terms of (i) the role of magnetic resonance imaging (MRI); (ii) which steroid treatment should be considered as adequate; and (iii) the response to treatment. Of 536 articles, 48, reporting on 62 patients, met the inclusion criteria. MRI was positive in 92.1% of the cases and it normalized after clinical resolution. There was no evidence of which steroid schedule should be considered as adequate; high-dose steroids are likely to be more effective both to induce resolution and to avoid recurrences. Pain subsided within the time limit required by the ICHD-II criteria, but signs did not. We conclude that THS diagnostic criteria can be improved on the basis of currently available data. MRI should play a pivotal role both to diagnose and to follow-up THS.

show abstract

Section: Resultsmentioning

confidence: 99%

ICHD-II Diagnostic Criteria for Tolosa—Hunt Syndrome in Idiopathic Inflammatory Syndromes of the Orbit and/or the Cavernous Sinus

et al. 2008

View full text Add to dashboard Cite

show abstract

“…Tamoxifen is a non-steroidal selective oestrogen-receptor modulator (SERM) of the triphenylethylene family, which include clomifene, nafoxidine, ospemifene and toremifene [ 101 , 102 ]; and is structurally derived from diethylstilbestrol-type oestrogens and antioestrogens, such as chlorotrianisene and ethamoxytriphetol. Clomiphene was synthesized initially and then tamoxifen was developed [ 103 – 105 ].…”

Section: Managementmentioning

confidence: 99%

IgG4-related sclerosing thyroiditis (Riedel-Struma): a review of clinicopathological features and management

Czarnywojtek

Pietrończyk²,

Thompson

et al. 2023

Virchows Arch

View full text Add to dashboard Cite

We present a thorough review of the literature on Riedel thyroiditis (RT) with emphasis on aetiology, diagnosis and management, using the PubMed, Sinomed, and China National Knowledge Infrastructure databases. Although the exact aetiology of RT remains obscure, the histopathological features are consistent with a localized form of IgG4-related systemic disease (IgG4-RSD). Nevertheless, IgG4-RSD as a systemic fibroinflammatory disorder per se rarely affects the thyroid in the context of multiorgan manifestations. The initial diagnosis of RT is based on clinical history and imaging, but confirmation by histopathological examination is mandatory. In contrast to the historical surgical approach, glucocorticosteroid therapy is currently considered first line therapy, in line with the RT currently being viewed as a manifestation of, or analogous to, IgG4-RSD. For disease relapse, immunomodulatory agents (azathioprine, methotrexate, rituximab) can be used.

show abstract

“…Evidence for this pathogenic mechanism comes from associations between Reidel's thyroiditis and other forms of fibroinflammatory disease [idiopathic retroperitoneal fibrosis, inflammatory pseudotumors, sclerosing cholangitis, and Tolosa-Hunt syndrome (3)(4)(5)(6)]. Additionally, Reidel's thyroiditis may have an immune component as evidenced by reports of antimicrosomal and antithyroglobulin antibodies in some patients with Reidel's thyroiditis (7).…”

Section: Introductionmentioning

confidence: 99%

Combined Mycophenolate Mofetil and Prednisone Therapy in Tamoxifen- and Prednisone-Resistant Reidel's Thyroiditis

Levy

Hasney

Friedlander

et al. 2010

Thyroid

View full text Add to dashboard Cite

show abstract

Reidel’s thyroiditis and Tolosa-Hunt syndrome, a rare association

Cited by 8 publications

References 6 publications

ICHD-II Diagnostic Criteria for Tolosa—Hunt Syndrome in Idiopathic Inflammatory Syndromes of the Orbit and/or the Cavernous Sinus

ICHD-II Diagnostic Criteria for Tolosa—Hunt Syndrome in Idiopathic Inflammatory Syndromes of the Orbit and/or the Cavernous Sinus

IgG4-related sclerosing thyroiditis (Riedel-Struma): a review of clinicopathological features and management

Combined Mycophenolate Mofetil and Prednisone Therapy in Tamoxifen- and Prednisone-Resistant Reidel's Thyroiditis

Contact Info

Product

Resources

About